Prescient Therapeutics Ltd

  • IPO date:
  • Sector: Healthcare
  • GIC Group: Pharmaceuticals, Biotechnology & Life Sciences
  • Industry: Biotechnology
  • Company website

Company description

Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-200, which is in Phase 2a clinical trial for HER2-negative breast cancer, Phase IB/2 clinical trial in relapsed and refractory AML, and Phase 1b in recurrent or persistent platinum-resistant ovarian cancer; and PTX-100, a RhoA inhibitor, for hematological and solid malignancies that focuses on cancers with Ras and RhoA mutations. It has a strategic collaboration with The University of Texas MD Anderson Cancer Center to develop blood cancer binder for OmniCAR. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. The company was incorporated in 1986 and is based in Melbourne, Australia.

Financial highlights

Market Capitalization$47.5139 million
P/E Ratio0
P/E Growth Ratio
Book Value0.032
Dividend Per Share0
Earnings Per Share-0.01
EBITDA-7,455.777
Profit Margin-2.8847
Operating Margin TTM-3.0715
Return on Assets TTM-0.2039
Return on Equity TTM-0.327
Revenue TTM2,428.123

Income statement highlights

All numbers are in thousands

Date Total Revenue Cost of Revenue Gross Profit Total Operating Expenses
1989-06-30
1990-06-30
1991-06-30
1992-06-30
1993-06-30
1994-06-30
1995-06-30
1996-06-30
1997-06-30
1998-06-30
1999-06-30
2000-06-30 272
2001-06-30 712 3,005.517
2002-06-30 435 435 3,186.08
2003-06-30 154.046 154.046 3,517.839
2004-06-30 175 4,138.845
2005-06-30 1,420 1,420 5,604.313
2006-06-30 208.693 208.693 4,994.053
2007-06-30 1,543.406 1,543.406 6,315.756
2008-06-30 364.877 364.877 2,710.827
2009-06-30 1,706.401
2010-06-30 2,098.665
2011-06-30 2,074.38
2012-06-30 1,968.591
2013-06-30 455.082
2014-06-30 8.142 0 8.142 924.856
2015-06-30 39.97 0 251.086 2,384.461
2016-06-30 10.704 0 10.704 2,749.6
2017-06-30 166.22 0 1,224.241 3,762.953
2018-06-30 125.16 0 939.771 3,607.484
2019-06-30 72.11 1,647.759 5,545.076
2020-06-30 70.36 4,494.269
2021-06-30 66.29 5,427.579
2022-06-30 44.18 7,100.684
2023-06-30 459.1 9,888.076

Balance sheet highlights

All numbers are in thousands

Date Cash Total Assets Total Liabilities Short Term Debt Long Term Debt Common Stock
1989-06-30 75 6,562 5,491 2,322
1990-06-30 1,356 7,181 5,389 2,257
1991-06-30 285 7,084 5,425 2,415
1992-06-30 223 6,846 5,675 2,415
1993-06-30 11 5,549 5,003 2,415
1994-06-30 20 5,901 5,565 3,366
1995-06-30 663 2,249 2,383 3,120
1996-06-30 24.156 24.156 65.703 3,120.625
1997-06-30 150.263 161.764 137.428 1,706.685
1998-06-30 1,015.613 1,235.046 61.978 3,161.448
1999-06-30 2,715.815 2,797.739 119.7 7,472.173
2000-06-30 1,355.241 1,384.163 107.613 8,353.002
2001-06-30 3,735.481 4,282.18 667.73 3,861 12,984.102
2002-06-30 1,821.489 1,904.438 448.423 1,562 13,473.161
2003-06-30 1,536.143 1,633.603 680 1,100 16,106.037
2004-06-30 3,811.996 4,148.056 510.813 3,650 22,753.128
2005-06-30 4,110.867 4,182.793 1,352.775 2,550 25,944.729
2006-06-30 3,553.167 3,707.626 1,680.512 29,667.114
2007-06-30 1,574.264 3,244.294 1,476.396 31,973.259
2008-06-30 1,631.294 1,750.467 1,677.415 1,305 31,973.335
2009-06-30 1,070.63 1,181.674 1,786.152 1,508.285 32,641.738
2010-06-30 1,383.68 1,567.567 1,288.738 897 35,103.714
2011-06-30 584.47 701.856 1,533.89 1,035.358 35,298.24
2012-06-30 29.18 61.824 1,848.824 1,100.129 36,216.338
2013-06-30 36,216.338
2014-06-30 3,808.562 5,279.715 252.893 42,496.592
2015-06-30 1,042.896 4,891.614 441.128 43,994.092
2016-06-30 9,753.646 13,835.073 822.551 54,276.559
2017-06-30 7,645.388 12,229.848 444.895 20 55,497.148
2018-06-30 5,485.902 9,990.823 551.56 56.046 55,570.683
2019-06-30 9,639.637 15,006.727 685.793 20 63,930.411
2020-06-30 7,357.078 12,072.11 883.951 156.88 63,930.411
2021-06-30 16,097.508 20,966.944 539.677 165.829 76,671.176
2022-06-30 12,263.839 17,618.425 856.013 0 77,264.264
2023-06-30 5,895.43 28,108.358 2,032.906 0 93,246.404

Cash flow highlights

All numbers are in thousands

Date Net Income Total Cash Change in Cash Begin period cash End period cash Dividends
1989-06-30 -92
1990-06-30 200 1,067
1991-06-30 -220 -850 1,067 217 261
1992-06-30 -21 -121 217 96 11
1993-06-30 -196 96 -100 34
1994-06-30 -157 -100 -257 322
1995-06-30 898 -257 641 17
1996-06-30 -616.92 641.076 24.156
1997-06-30 126.107 24.156 150.263
1998-06-30 865.35 150.263 1,015.613
1999-06-30 -1,424.998 1,700.202 1,015.613 2,715.815
2000-06-30 -2,282.318 -1,360.574 2,715.815 1,355.241
2001-06-30 -2,293.2 2,380.24 1,355.241 3,735.481
2002-06-30 -2,647.494 -1,913.993 3,735.481 1,821.488
2003-06-30 -3,135.288 -285.345 1,821.488 1,536.143
2004-06-30 -3,963.451 2,275.853 1,536.143 3,811.996
2005-06-30 -3,998.826 298.871 3,811.996 4,110.867
2006-06-30 -4,625.343 -557.7 4,110.867 3,553.167
2007-06-30 -2,667.326 -1,978.903 3,553.167 1,574.264
2008-06-30 -1,773.449 57.03 1,574.264 1,631.294
2009-06-30 -1,345.933 -560.664 1,631.294 1,070.63
2010-06-30 -1,864.246 313.05 1,070.63 1,383.68
2011-06-30 -1,361.594 -799.21 1,383.68 584.47
2012-06-30 -1,892.37 -555.29 584.47 29.18
2013-06-30 1,787 29.18
2014-06-30 -1,296.896 -1,127.309 3,808.562 3,808.562
2015-06-30 -2,133.375 -2,240.66 -2,765.666 3,808.562 1,042.896
2016-06-30 -1,754.142 -1,558.91 8,710.75 1,042.896 9,753.646
2017-06-30 -2,567.633 -3,278.24 -2,108.258 9,753.646 7,645.388
2018-06-30 -2,573.73 -2,149.126 -2,159.486 7,645.388 5,485.902
2019-06-30 -3,797.227 -4,195.468 4,153.735 5,485.902 9,639.637
2020-06-30 -3,321.189 -2,317.182 -2,282.559 9,639.637 7,357.078
2021-06-30 -4,148.819 -3,970.025 8,740.43 7,357.078 16,097.508
2022-06-30 -5,123.71 -5,122.307 -3,833.669 16,097.508 12,263.839
2023-06-30 -7,004.501 -6,191.003 -6,368.409 12,263.839 5,895.43